Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

504
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
504
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

641
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
641
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

501
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
501
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

184
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
184
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

910
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
910
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

1.6K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.6K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Letter: Assessing Pruritus Efficacy With Peroxisome Proliferator-Activated Receptor Agonists in Primary Biliary Cholangitis Must Include Grading the Strength of Trial Evidence.

Alimentary pharmacology & therapeutics·2026
Same author

Evolving Concepts of Treatment Targets for Primary Biliary Cholangitis: A Global Perspective.

The American journal of gastroenterology·2026
Same author

Can we cure primary biliary cholangitis?

Current opinion in immunology·2026
Same author

Reply: Fracture risk under selective and non-selective PPAR agonists in primary biliary cholangitis.

Hepatology communications·2026
Same author

Seronegative Autoimmune Hepatitis in Adults Is a Rare Entity Often Obscured by Suboptimal Diagnostic Assessment.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

From science to public health impact: Enacting the recommendations of the EASL-Lancet Commission on liver health in Europe.

Journal of hepatology·2026

関連する実験動画

Updated: Nov 26, 2025

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

537

主要な胆管炎

Ana Lleo1, Giu-Qiang Wang2, Merrill Eric Gershwin3

  • 1Department of Biomedical Sciences, Humanitas University, Milan, Italy; Division of Internal Medicine and Hepatology, Department of Gastroenterology, Humanitas Clinical and Research Center IRCCS, Rozzano, Italy.

Lancet (London, England)
|December 14, 2020
PubMed
まとめ
この要約は機械生成です。

原発性胆管炎 (PBC) は,主に女性に影響する自己免疫性肝疾患である. 治療はウルソデオキシコール酸に重点を置くが,治療に反応しない患者には補足療法としてオベチコール酸が用いられ,症状管理が不可欠である.

さらに関連する動画

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

16.2K

関連する実験動画

Last Updated: Nov 26, 2025

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

537
Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

16.2K

科学分野:

  • ヘパトロジー
  • 自己免疫 疾患
  • 胃腸内科

背景:

  • 主要胆管炎 (PBC) は,主に女性に影響する慢性自己免疫性肝疾患です.
  • 小さい胆管のリンパ球破壊によって特徴付けられ,コレスタシスと線維症につながります.
  • エチオロジーは免疫機能の損傷,遺伝的傾向,環境要因を含みます.

研究 の 目的:

  • 主要胆管炎の現在の理解と管理をレビューする.
  • 確立された治療戦略と新たな治療戦略を議論する.
  • リスクの階層化と症状管理の重要性を強調する.

主な方法:

  • 主要胆管炎の病原性,診断,治療に関する文献レビュー.
  • 現在の治療ガイドラインと臨床試験データの分析
  • 患者によって報告されたアウトカムに重点を置く.

主要な成果:

  • ウルソデオキシコール酸は,コレスタシスの主要な治療法です.
  • オベチコル酸は,不十分な応答者のための追加療法として機能します.
  • ベザフィブラートと試験薬は 代替の治療法であり 将来の治療法である.
  • リスクの階層化は,ベースラインの特徴と肝損傷マーカー (ビリルビン,ALP) を利用します.

結論:

  • PBCの効果的な管理には,疾患の進行と患者の症状の両方に対処する必要があります.
  • 結果を最適化するために 個別化された治療アプローチは不可欠です
  • 進行中の研究は,PBCのための新しい治療法を開発することを目的としています.